Demand is soaring for an “antibody cocktail” that can greatly diminish the severity of coronavirus cases, Michigan Radio reported.
The antibody cocktail created by Regeneron is the same former President Donald Trump received after he contracted the virus and is intended to be administered only after a patient has contracted the disease. Read More
As confirmed cases of the coronavirus continue to rise throughout the country, monoclonal antibody treatments, such as Regeneron, are becoming a widespread source of treatment.
Across the state of Tennessee, hundreds of locations are providing the treatment to individuals who have tested positive for the virus. Read More
Governor DeSantis expressed his support for Regeneron’s monoclonal antibody treatment Thursday, as COVID cases and the number of hospitalizations continue to surge in Florida.
According to DeSantis, “These treatments have been proven successful, with clinical trials resulting in a 70% reduction in hospitalization and death for COVID patients,” especially those who have higher risk for severe complications due to age or preexisting medical conditions.
As reported by the Food and Drug Administration (FDA), “Monoclonal antibodies are laboratory-made proteins that mimic the immune system’s ability to fight off harmful antigens such as viruses.” The treatment is meant for individuals who have tested positive or recovered from COVID. Read More